Andrew L. Croxford

Andrew L. Croxford

Auto-generated profile, based on publicly available information

Andrew L. Croxford

Institute of Experimental Immunology, University of Zürich, Zürich 8057, Switzerland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RPRoham Parsa
Roham Parsa
HLHarald Lund
Harald Lund
AGAnna-Maria Georgoudaki
Anna-Maria Georgoudaki
XZXing-Mei Zhang
Xing-Mei Zhang
AGAndré Ortlieb Guerreiro-Cacais
André Ortlieb Guerreiro-Cacais
RHRobert A. Harris
Robert A. Harris
Prolonged infections or adjuvant usage can trigger emergency granulopoiesis (EG), leading to dysregulation in neutrophil blood counts. However, the impact of EG on T and B cell function remains largely unknown. In this study, to address this question, we used a mouse model of neutropenia and studied immune activation after adjuvant administration. The initial neutropenic state fostered an environment of increased dendritic cell activation and T cell–derived IL-17 production. Interestingly, neutropenic lysozyme 2–diphtheria toxin A mice exhibited striking EG and amplified neutrophil recruitment to the lymph nodes (LNs) that was dependent on IL-17–induced prostaglandin activity. The recruited neutrophils secreted a B cell–activating factor that highly accelerated plasma cell generation and antigen-specific antibody production. Reduction of neutrophil functions via granulocyte colony-stimulating factor neutralization significantly diminished plasma cell formation, directly linking EG with the humoral immune response. We conclude that neutrophils are capable of directly regulating T cell–dependent B cell responses in the LN.

1 January 2016 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
PKPaulina Kulig
Paulina Kulig
SBSara Burkhard
Sara Burkhard
JMJoanna Mikita-Geoffroy
Joanna Mikita-Geoffroy
ACAndrew L. Croxford
Andrew L. Croxford
NHNadine Hövelmeyer
Nadine Hövelmeyer
BBBurkhard Becher
Burkhard Becher
The role of the IL23/IL17A axis in tumor–immune interactions is a matter of controversy. Although some suggest that IL17A-producing T cells (TH17) can suppress tumor growth, others report that IL17A and IL23 accelerate tumor growth. Here, we systematically assessed the impact of IL17A-secreting lymphocytes in several murine models of tumor lung metastasis. Genetic fate mapping revealed that IL17A was secreted within lung metastases predominantly by γδ T cells, whereas TH17 cells were virtually absent. Using different tumor models, we found Il17a−/− mice to consistently develop fewer pulmonary tumor colonies. IL17A specifically increased blood vessel permeability and the expression of E-selectin and VCAM-1 by lung endothelial cells in vivo. In transgenic mice, specific targeting of IL17A to the endothelium increased the number of tumor foci. Moreover, the direct impact of IL17A on lung endothelial cells resulted in impaired endothelial barrier integrity, showing that IL17A promotes the formation of lung metastases through tumor-endothelial transmigration. Cancer Immunol Res; 4(1); 26–32. ©2015 AACR.

4 February 2020 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DTDamini Tewari
Damini Tewari
ACAndrew D. Cook
Andrew D. Cook
MLMing-Chin Lee
Ming-Chin Lee
ACAnne D. Christensen
Anne D. Christensen
ACAndrew Croxford
Andrew Croxford
SMStephen B. McMahon
Stephen B. McMahon
The interaction between the immune system and the nervous system has been at the center of multiple research studies in recent years. Whereas the role played by cytokines as neuronal mediators is no longer contested, the mechanisms by which cytokines modulate pain processing remain to be elucidated. In this study, we have analyzed the involvement of granulocyte-macrophage colony stimulating factor (GM-CSF) in nociceptor activation in male and female mice. Previous studies have suggested GM-CSF might directly activate neurons. However, here we established the absence of a functional GM-CSF receptor in murine nociceptors, and suggest an indirect mechanism of action, via immune cells. We report that GM-CSF applied directly to magnetically purified nociceptors does not induce any transcriptional changes in nociceptive genes. In contrast, conditioned medium from GM-CSF-treated murine macrophages was able to drive nociceptor transcription. We also found that conditioned medium from nociceptors treated with the well established pain mediator, nerve growth factor, could also modify macrophage gene transcription, providing further evidence for a bidirectional crosstalk.SIGNIFICANCE STATEMENTThe interaction of the immune system and the nervous system is known to play an important role in the development and maintenance of chronic pain disorders. Elucidating the mechanisms of these interactions is an important step toward understanding, and therefore treating, chronic pain disorders. This study provides evidence for a two-way crosstalk between macrophages and nociceptors in the peripheral nervous system, which may contribute to the sensitization of nociceptors by cytokines in pain development.

3 April 2023
Verified
Other
Open access
PKPaulina Kulig
Paulina Kulig
SBSara Burkhard
Sara Burkhard
JMJoanna Mikita-Geoffroy
Joanna Mikita-Geoffroy
ACAndrew L. Croxford
Andrew L. Croxford
NHNadine Hövelmeyer
Nadine Hövelmeyer
BBBurkhard Becher
Burkhard Becher

3 April 2023
Verified
Other
Open access
PKPaulina Kulig
Paulina Kulig
SBSara Burkhard
Sara Burkhard
JMJoanna Mikita-Geoffroy
Joanna Mikita-Geoffroy
ACAndrew L. Croxford
Andrew L. Croxford
NHNadine Hövelmeyer
Nadine Hövelmeyer
BBBurkhard Becher
Burkhard Becher

3 April 2023
Verified
Other
Open access
PKPaulina Kulig
Paulina Kulig
SBSara Burkhard
Sara Burkhard
JMJoanna Mikita-Geoffroy
Joanna Mikita-Geoffroy
ACAndrew L. Croxford
Andrew L. Croxford
NHNadine Hövelmeyer
Nadine Hövelmeyer
BBBurkhard Becher
Burkhard Becher